ArticleCancer biology & therapy2021

Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.

David S Weinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.